O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	14	15	I	I	B-NP	NN	B-protein	6	NMOD	B-protein
T1	I-Protein	16	21	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T1	I-Protein	22	23	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
T1	I-Protein	24	29	alpha	alpha	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	30	33	and	and	O	CC	O	8	NMOD	O
T2	B-Protein	34	38	p105	p105	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	39	41	in	in	B-PP	IN	O	1	NMOD	O
O	O	42	51	monocytes	monocyte	B-NP	NNS	B-cell_type	12	NMOD	B-cell_type
O	O	52	55	and	and	O	CC	O	12	NMOD	O
O	O	56	67	macrophages	macrophage	B-NP	NNS	B-cell_type	9	PMOD	B-cell_type
O	O	68	80	persistently	persistently	B-VP	RB	O	14	VMOD	O
O	O	81	89	infected	infect	I-VP	VBN	O	12	NMOD	O
O	O	90	94	with	with	B-PP	IN	O	14	VMOD	O
O	O	95	100	human	human	B-NP	JJ	O	18	NMOD	O
O	O	101	117	immunodeficiency	immunodeficiency	I-NP	NN	O	18	NMOD	O
O	O	118	123	virus	virus	I-NP	NN	O	15	PMOD	O
O	O	123	124	.	.	O	.	O	1	P	O

O	O	126	129	The	The	B-NP	DT	O	2	NMOD	O
O	O	130	140	mechanisms	mechanism	I-NP	NNS	O	16	SUB	O
O	O	141	151	regulating	regulate	B-VP	VBG	O	2	NMOD	O
O	O	152	157	human	human	B-NP	JJ	O	6	NMOD	O
O	O	158	174	immunodeficiency	immunodeficiency	I-NP	NN	O	6	NMOD	O
O	O	175	180	virus	virus	I-NP	NN	O	10	NMOD	O
O	O	181	182	(	(	O	(	O	9	DEP	O
O	O	182	185	HIV	HIV	B-NP	NN	O	9	DEP	O
O	O	185	186	)	)	O	)	O	6	NMOD	O
O	O	187	198	persistence	persistence	B-NP	NN	O	3	OBJ	O
O	O	199	201	in	in	B-PP	IN	O	10	NMOD	O
O	O	202	207	human	human	B-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	208	217	monocytes	monocyte	I-NP	NNS	I-cell_type	15	NMOD	I-cell_type
O	O	217	218	/	/	O	SYM	B-cell_type	15	NMOD	B-cell_type
O	O	218	229	macrophages	macrophage	B-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	230	233	are	be	B-VP	VBP	O	0	ROOT	O
O	O	234	243	partially	partially	I-VP	RB	O	16	VMOD	O
O	O	244	254	understood	understand	I-VP	VBN	O	16	VC	O
O	O	254	255	.	.	O	.	O	16	P	O

O	O	256	266	Persistent	Persistent	B-NP	JJ	O	3	NMOD	O
O	O	267	270	HIV	HIV	I-NP	NN	O	3	NMOD	O
O	O	271	280	infection	infection	I-NP	NN	O	8	SUB	O
O	O	281	283	of	of	B-PP	IN	O	3	NMOD	O
O	O	284	288	U937	U937	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	289	298	monocytic	monocytic	I-NP	JJ	I-cell_line	7	NMOD	I-cell_line
O	O	299	304	cells	cell	I-NP	NNS	I-cell_line	4	PMOD	I-cell_line
O	O	305	312	results	result	B-VP	VBZ	O	0	ROOT	O
O	O	313	315	in	in	B-PP	IN	O	8	VMOD	O
T14	B-Entity	316	318	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T14	I-Entity	318	319	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T14	I-Entity	319	324	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T14	I-Entity	325	326	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	327	337	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	337	338	.	.	O	.	O	8	P	O

O	O	339	346	Whether	Whether	B-PP	IN	O	20	SUB	O
O	O	347	352	virus	virus	B-NP	NN	O	4	AMOD	O
O	O	352	353	-	-	O	HYPH	O	2	P	O
O	O	353	360	induced	induce	B-NP	VBN	O	9	NMOD	O
T15	B-Entity	361	363	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T15	I-Entity	363	364	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T15	I-Entity	364	369	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T15	I-Entity	370	371	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	372	382	activation	activation	I-NP	NN	O	10	SUB	O
O	O	383	385	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	386	387	a	a	B-NP	DT	O	12	NMOD	O
O	O	388	397	mechanism	mechanism	I-NP	NN	O	10	PRD	O
O	O	398	402	that	that	B-NP	WDT	O	12	NMOD	O
O	O	403	409	favors	favor	B-VP	VBZ	O	13	SBAR	O
O	O	410	420	continuous	continuous	B-NP	JJ	O	17	NMOD	O
O	O	421	426	viral	viral	I-NP	JJ	O	17	NMOD	O
O	O	427	438	replication	replication	I-NP	NN	O	14	OBJ	O
O	O	439	441	in	in	B-PP	IN	O	17	NMOD	O
O	O	442	453	macrophages	macrophage	B-NP	NNS	B-cell_type	18	PMOD	B-cell_type
O	O	454	461	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	462	469	unknown	unknown	B-ADJP	JJ	O	20	PRD	O
O	O	469	470	.	.	O	.	O	20	P	O

O	O	471	473	To	To	B-VP	TO	O	3	VMOD	O
O	O	474	481	further	further	I-VP	RB	O	3	VMOD	O
O	O	482	491	delineate	delineate	I-VP	VB	O	25	VMOD	O
O	O	492	495	the	the	B-NP	DT	O	6	NMOD	O
O	O	496	505	molecular	molecular	I-NP	JJ	O	6	NMOD	O
O	O	506	516	mechanisms	mechanism	I-NP	NNS	O	3	OBJ	O
O	O	517	525	involved	involve	B-VP	VBN	O	6	NMOD	O
O	O	526	528	in	in	B-PP	IN	O	7	VMOD	O
O	O	529	532	the	the	B-NP	DT	O	10	NMOD	O
O	O	533	543	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	544	546	of	of	B-PP	IN	O	10	NMOD	O
T16	B-Entity	547	549	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T16	I-Entity	549	550	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T16	I-Entity	550	555	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T16	I-Entity	556	557	B	B	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	558	560	in	in	B-PP	IN	O	10	NMOD	O
O	O	561	564	HIV	HIV	B-NP	NN	O	22	NMOD	O
O	O	564	565	-	-	O	HYPH	O	22	P	O
O	O	565	573	infected	infect	B-VP	VBN	O	22	NMOD	O
O	O	574	583	monocytes	monocyte	B-NP	NNS	B-cell_type	22	NMOD	B-cell_type
O	O	584	587	and	and	O	CC	O	22	NMOD	O
O	O	588	599	macrophages	macrophage	B-NP	NNS	B-cell_type	16	PMOD	B-cell_type
O	O	599	600	,	,	O	,	O	25	P	O
O	O	601	603	we	we	B-NP	PRP	O	25	SUB	O
O	O	604	608	have	have	B-VP	VBP	O	0	ROOT	O
O	O	609	616	focused	focus	I-VP	VBN	O	25	VC	O
O	O	617	619	on	on	B-PP	IN	O	26	VMOD	O
O	O	620	623	the	the	B-NP	DT	O	29	NMOD	O
O	O	624	634	regulation	regulation	I-NP	NN	O	27	PMOD	O
O	O	635	637	of	of	B-PP	IN	O	29	NMOD	O
O	O	638	641	the	the	B-NP	DT	O	35	NMOD	O
O	O	642	643	I	I	I-NP	NN	B-protein	35	NMOD	B-protein
O	O	644	649	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	650	651	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	652	661	molecules	molecule	I-NP	NNS	I-protein	30	PMOD	I-protein
O	O	661	662	.	.	O	.	O	25	P	O

O	O	663	668	First	First	B-ADVP	RB	O	4	VMOD	O
O	O	668	669	,	,	O	,	O	4	P	O
O	O	670	672	we	we	B-NP	PRP	O	4	SUB	O
O	O	673	677	show	show	B-VP	VBP	O	0	ROOT	O
O	O	678	682	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	683	693	persistent	persistent	B-NP	JJ	O	8	NMOD	O
O	O	694	697	HIV	HIV	I-NP	NN	O	8	NMOD	O
O	O	698	707	infection	infection	I-NP	NN	O	9	SUB	O
O	O	708	715	results	result	B-VP	VBZ	O	5	SBAR	O
O	O	716	718	in	in	B-PP	IN	O	9	VMOD	O
O	O	719	722	the	the	B-NP	DT	O	12	NMOD	O
O	O	723	733	activation	activation	I-NP	NN	O	10	PMOD	O
O	O	734	736	of	of	B-PP	IN	O	12	NMOD	O
T17	B-Entity	737	739	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T17	I-Entity	739	740	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T17	I-Entity	740	745	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T17	I-Entity	746	747	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	748	751	not	not	B-CONJP	RB	O	12	NMOD	O
O	O	752	756	only	only	I-CONJP	RB	O	18	DEP	O
O	O	757	759	in	in	B-PP	IN	O	18	PMOD	O
O	O	760	769	monocytic	monocytic	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	770	775	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	776	779	but	but	B-CONJP	CC	O	18	PMOD	O
O	O	780	784	also	also	I-CONJP	RB	O	23	DEP	O
O	O	785	787	in	in	B-PP	IN	O	18	PMOD	O
O	O	788	799	macrophages	macrophage	B-NP	NNS	B-cell_type	25	PMOD	B-cell_type
O	O	799	800	.	.	O	.	O	4	P	O

O	O	801	803	In	In	B-PP	IN	O	13	VMOD	O
O	O	804	807	HIV	HIV	B-NP	NN	O	5	NMOD	O
O	O	807	808	-	-	B-NP	HYPH	O	5	NMOD	O
O	O	808	816	infected	infect	I-NP	VBN	B-cell_type	5	NMOD	B-cell_type
O	O	817	822	cells	cell	I-NP	NNS	I-cell_type	1	PMOD	I-cell_type
O	O	822	823	,	,	O	,	O	13	P	O
T3	B-Protein	824	825	I	I	B-NP	NN	B-protein	12	NMOD	B-protein
T3	I-Protein	826	831	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T3	I-Protein	832	833	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
T3	I-Protein	834	839	alpha	alpha	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	840	847	protein	protein	I-NP	NN	O	12	NMOD	O
O	O	848	854	levels	level	I-NP	NNS	O	13	SUB	O
O	O	855	858	are	be	B-VP	VBP	O	0	ROOT	O
O	O	859	868	decreased	decrease	I-VP	VBN	O	13	VC	O
O	O	869	878	secondary	secondary	B-ADJP	JJ	O	14	VMOD	O
O	O	879	881	to	to	B-PP	TO	O	15	AMOD	O
O	O	882	890	enhanced	enhance	B-NP	VBN	O	19	NMOD	O
O	O	891	898	protein	protein	I-NP	NN	O	19	NMOD	O
O	O	899	910	degradation	degradation	I-NP	NN	O	16	PMOD	O
O	O	910	911	.	.	O	.	O	13	P	O

O	O	912	916	This	This	B-NP	DT	O	2	SUB	O
O	O	917	926	parallels	parallel	B-VP	VBZ	O	0	ROOT	O
O	O	927	930	the	the	B-NP	DT	O	9	NMOD	O
O	O	931	940	increased	increase	I-NP	VBN	O	9	NMOD	O
T4	B-Protein	941	942	I	I	I-NP	NN	B-protein	8	NMOD	B-protein
T4	I-Protein	943	948	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T4	I-Protein	949	950	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
T4	I-Protein	951	956	alpha	alpha	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	957	966	synthesis	synthesis	I-NP	NN	O	20	NMOD	O
O	O	967	976	secondary	secondary	B-ADJP	JJ	O	9	NMOD	O
O	O	977	979	to	to	B-PP	TO	O	10	AMOD	O
O	O	980	989	increased	increase	B-NP	VBN	O	18	NMOD	O
T5	B-Protein	990	991	I	I	I-NP	NN	B-protein	17	NMOD	B-protein
T5	I-Protein	992	997	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	998	999	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	1000	1005	alpha	alpha	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	1006	1010	gene	gene	I-NP	NN	O	18	NMOD	O
O	O	1011	1024	transcription	transcription	I-NP	NN	O	11	PMOD	O
O	O	1024	1025	,	,	O	,	O	20	P	O
O	O	1026	1027	i	i	B-NP	NN	O	2	OBJ	O
O	O	1027	1028	.	.	O	.	O	20	NMOD	O
O	O	1028	1029	e	e	B-NP	NN	O	29	NMOD	O
O	O	1029	1030	.	.	O	.	O	22	P	O
O	O	1030	1031	,	,	O	,	O	29	P	O
O	O	1032	1041	increased	increase	B-NP	VBN	O	29	NMOD	O
O	O	1042	1045	RNA	RNA	I-NP	NN	O	29	NMOD	O
O	O	1046	1049	and	and	I-NP	CC	O	29	NMOD	O
O	O	1050	1065	transcriptional	transcriptional	I-NP	JJ	O	29	NMOD	O
O	O	1066	1074	activity	activity	I-NP	NN	O	21	PMOD	O
O	O	1075	1077	of	of	B-PP	IN	O	29	NMOD	O
O	O	1078	1081	its	its	B-NP	PRP$	O	34	NMOD	O
T18	B-Entity	1082	1090	promoter	promoter	I-NP	NN	B-DNA	34	NMOD	B-DNA
T18	I-Entity	1090	1091	-	-	I-NP	HYPH	I-DNA	34	NMOD	I-DNA
T18	I-Entity	1091	1099	enhancer	enhancer	I-NP	NN	I-DNA	30	PMOD	I-DNA
O	O	1099	1100	.	.	O	.	O	2	P	O

O	O	1101	1108	Another	Another	B-NP	DT	O	2	NMOD	O
O	O	1109	1116	protein	protein	I-NP	NN	O	9	NMOD	O
O	O	1117	1121	with	with	B-PP	IN	O	2	NMOD	O
O	O	1122	1123	I	I	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	1124	1129	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1130	1131	B	B	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1132	1140	function	function	I-NP	NN	O	3	PMOD	O
O	O	1140	1141	,	,	O	,	O	9	P	O
T6	B-Protein	1142	1146	p105	p105	B-NP	NN	B-protein	11	SUB	B-protein
O	O	1146	1147	,	,	O	,	O	9	P	O
O	O	1148	1150	is	be	B-VP	VBZ	O	28	VMOD	O
O	O	1151	1155	also	also	I-VP	RB	O	11	VMOD	O
O	O	1156	1164	modified	modify	I-VP	VBN	O	11	VC	O
O	O	1165	1167	in	in	B-PP	IN	O	13	VMOD	O
O	O	1168	1171	HIV	HIV	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	1171	1172	-	-	B-NP	HYPH	I-cell_type	18	NMOD	I-cell_type
O	O	1172	1180	infected	infect	I-NP	VBN	I-cell_type	18	NMOD	I-cell_type
O	O	1181	1186	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	1186	1187	:	:	O	:	O	11	P	O
T7	B-Protein	1188	1192	p105	p105	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	1193	1196	and	and	O	CC	O	27	NMOD	O
T8	B-Protein	1197	1200	p50	p50	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	1201	1207	steady	steady	I-NP	JJ	O	27	NMOD	O
O	O	1207	1208	-	-	I-NP	HYPH	O	27	NMOD	O
O	O	1208	1213	state	state	I-NP	NN	O	27	NMOD	O
O	O	1214	1221	protein	protein	I-NP	NN	O	27	NMOD	O
O	O	1222	1228	levels	level	I-NP	NNS	O	28	SUB	O
O	O	1229	1232	are	be	B-VP	VBP	O	0	ROOT	O
O	O	1233	1242	increased	increase	I-VP	VBN	O	28	VC	O
O	O	1243	1245	as	as	B-PP	IN	O	29	VMOD	O
O	O	1246	1247	a	a	B-NP	DT	O	32	NMOD	O
O	O	1248	1254	result	result	I-NP	NN	O	30	PMOD	O
O	O	1255	1257	of	of	B-PP	IN	O	32	NMOD	O
O	O	1258	1267	increased	increase	B-NP	VBN	O	38	NMOD	O
O	O	1268	1277	synthesis	synthesis	I-NP	NN	O	38	NMOD	O
O	O	1278	1281	and	and	I-NP	CC	O	38	NMOD	O
O	O	1282	1293	proteolytic	proteolytic	I-NP	JJ	O	38	NMOD	O
O	O	1294	1304	processing	processing	I-NP	NN	O	33	PMOD	O
O	O	1305	1307	of	of	B-PP	IN	O	38	NMOD	O
T9	B-Protein	1308	1312	p105	p105	B-NP	NN	B-protein	39	PMOD	B-protein
O	O	1312	1313	.	.	O	.	O	28	P	O

O	O	1314	1329	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD	O
O	O	1330	1338	activity	activity	I-NP	NN	O	5	SUB	O
O	O	1339	1341	of	of	B-PP	IN	O	2	NMOD	O
T10	B-Protein	1342	1346	p105	p105	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	1347	1349	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1350	1354	also	also	I-VP	RB	O	5	VMOD	O
O	O	1355	1364	increased	increase	I-VP	VBN	O	5	VC	O
O	O	1365	1367	in	in	B-PP	IN	O	7	VMOD	O
O	O	1368	1376	infected	infected	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	1377	1382	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	1383	1386	and	and	O	CC	O	5	VMOD	O
O	O	1387	1389	is	be	B-VP	VBZ	O	5	VMOD	O
O	O	1390	1394	also	also	I-VP	RB	O	12	VMOD	O
O	O	1395	1403	mediated	mediate	I-VP	VBN	O	12	VC	O
O	O	1404	1406	by	by	B-PP	IN	O	14	VMOD	O
T19	B-Entity	1407	1409	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T19	I-Entity	1409	1410	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T19	I-Entity	1410	1415	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T19	I-Entity	1416	1417	B	B	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	1418	1425	through	through	B-PP	IN	O	14	VMOD	O
O	O	1426	1427	a	a	B-NP	DT	O	25	NMOD	O
O	O	1428	1436	specific	specific	I-NP	JJ	O	25	NMOD	O
T20	B-Entity	1437	1442	kappa	kappa	I-NP	NN	B-DNA	25	NMOD	B-DNA
T20	I-Entity	1443	1444	B	B	I-NP	NN	I-DNA	25	NMOD	I-DNA
T20	I-Entity	1445	1450	motif	motif	I-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	1450	1451	.	.	O	.	O	5	P	O

O	O	1452	1457	These	These	B-NP	DT	O	2	NMOD	O
O	O	1458	1465	results	result	I-NP	NNS	O	3	SUB	O
O	O	1466	1477	demonstrate	demonstrate	B-VP	VBP	O	23	VMOD	O
O	O	1478	1481	the	the	B-NP	DT	O	5	NMOD	O
O	O	1482	1491	existence	existence	I-NP	NN	O	3	OBJ	O
O	O	1492	1494	of	of	B-PP	IN	O	5	NMOD	O
O	O	1495	1496	a	a	B-NP	DT	O	10	NMOD	O
O	O	1497	1503	triple	triple	I-NP	JJ	O	10	NMOD	O
O	O	1504	1518	autoregulatory	autoregulatory	I-NP	JJ	O	10	NMOD	O
O	O	1519	1523	loop	loop	I-NP	NN	O	6	PMOD	O
O	O	1524	1526	in	in	B-PP	IN	O	10	NMOD	O
O	O	1527	1536	monocytes	monocyte	B-NP	NNS	B-cell_type	14	NMOD	B-cell_type
O	O	1537	1540	and	and	O	CC	O	14	NMOD	O
O	O	1541	1552	macrophages	macrophage	B-NP	NNS	B-cell_type	11	PMOD	B-cell_type
O	O	1553	1562	involving	involve	B-VP	VBG	O	10	NMOD	O
O	O	1563	1566	HIV	HIV	B-NP	NN	O	20	NMOD	O
O	O	1566	1567	,	,	I-NP	,	O	20	P	O
T11	B-Protein	1568	1572	p105	p105	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	1573	1576	and	and	I-NP	CC	O	20	NMOD	O
T12	B-Protein	1577	1580	p50	p50	I-NP	NN	B-protein	15	OBJ	B-protein
O	O	1580	1581	,	,	O	,	O	23	P	O
O	O	1582	1585	and	and	O	CC	O	23	NMOD	O
T13	B-Protein	1586	1590	MAD3	MAD3	B-NP	NN	B-protein	0	ROOT	B-protein
O	O	1590	1591	,	,	O	,	O	23	P	O
O	O	1592	1596	with	with	B-PP	IN	O	23	NMOD	O
O	O	1597	1600	the	the	B-NP	DT	O	28	NMOD	O
O	O	1601	1604	end	end	I-NP	NN	O	28	NMOD	O
O	O	1605	1611	result	result	I-NP	NN	O	25	PMOD	O
O	O	1612	1614	of	of	B-PP	IN	O	28	NMOD	O
O	O	1615	1625	persistent	persistent	B-NP	JJ	O	35	NMOD	O
T21	B-Entity	1626	1628	NF	NF	I-NP	NN	B-protein	34	NMOD	B-protein
T21	I-Entity	1628	1629	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T21	I-Entity	1629	1634	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T21	I-Entity	1635	1636	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	1637	1647	activation	activation	I-NP	NN	O	38	NMOD	O
O	O	1648	1651	and	and	O	CC	O	38	NMOD	O
O	O	1652	1657	viral	viral	B-NP	JJ	O	38	NMOD	O
O	O	1658	1669	persistence	persistence	I-NP	NN	O	29	PMOD	O
O	O	1669	1670	.	.	O	.	O	23	P	O

O	O	1671	1682	Furthermore	Furthermore	B-ADVP	RB	O	10	VMOD	O
O	O	1682	1683	,	,	O	,	O	10	P	O
O	O	1684	1694	persistent	persistent	B-NP	JJ	O	5	NMOD	O
O	O	1695	1698	HIV	HIV	I-NP	NN	O	5	NMOD	O
O	O	1699	1708	infection	infection	I-NP	NN	O	10	SUB	O
O	O	1709	1711	of	of	B-PP	IN	O	5	NMOD	O
O	O	1712	1721	monocytes	monocyte	B-NP	NNS	B-cell_type	9	NMOD	B-cell_type
O	O	1722	1725	and	and	O	CC	O	9	NMOD	O
O	O	1726	1737	macrophages	macrophage	B-NP	NNS	B-cell_type	6	PMOD	B-cell_type
O	O	1738	1746	provides	provide	B-VP	VBZ	O	0	ROOT	O
O	O	1747	1748	a	a	B-NP	DT	O	13	NMOD	O
O	O	1749	1755	useful	useful	I-NP	JJ	O	13	NMOD	O
O	O	1756	1761	model	model	I-NP	NN	O	10	OBJ	O
O	O	1762	1766	with	with	B-PP	IN	O	13	NMOD	O
O	O	1767	1772	which	which	B-NP	WDT	O	14	PMOD	O
O	O	1773	1775	to	to	B-VP	TO	O	17	VMOD	O
O	O	1776	1781	study	study	I-VP	VB	O	14	SBAR	O
O	O	1782	1793	concomitant	concomitant	B-NP	JJ	O	19	NMOD	O
O	O	1794	1807	modifications	modification	I-NP	NNS	O	17	OBJ	O
O	O	1808	1810	of	of	B-PP	IN	O	19	NMOD	O
O	O	1811	1820	different	different	B-NP	JJ	O	20	PMOD	O
O	O	1821	1822	I	I	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	1823	1828	kappa	kappa	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	1829	1830	B	B	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	1831	1840	molecules	molecule	I-NP	NNS	I-protein	21	NMOD	I-protein
O	O	1840	1841	.	.	O	.	O	10	P	O
